SAFC, the custom manufacturing and services business unit of Sigma-Aldrich, announced that it added of 20 raw materials for biopharmaceutical manufacturing to its PharmaGrade portfolio and expects the line of buffers, amino acids, and specialty chemicals to double in size by the end of 2013.
Products in the PharmaGrade portfolio are provided with full documentation of manufacturing history, are compliant with either GMP (Good Manufacturing Practice) standards or the SAFC Elite Quality grade standards, and are quality assurance reviewed and released, according to a company announcement.
The company also announced an expansion of its manufacturing plant in Irvine, Scotland to include large-scale production of bulk dry power media and reagents. Designed to support the expanding needs of the European and Asia Pacific market, SAFC’s Irvine facility expansion will result in redundant manufacturing capabilities in conjunction with SAFC’s existing dry powder media facility in Lenexa, Kan.
SAFC will construct a purpose-built Animal Component Free (ACF) dry powder media manufacturing facility to complement the existing liquid cell culture media, buffers, and reagents capabilities in Irvine. Ground breaking for the new facility is expected to commence in March 2013 and should be manufacturing-ready in Q1 of 2014.